华仁药业 (300110.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(华仁药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
单季度财务指标:
 单季度销售毛利率(%) 32.0033.0042.0040.0047.0043.0042.00
 单季度销售净利率(%) 8.007.0013.0013.0015.0010.0010.00
 单季度净资产收益率ROE(%) 1.001.002.002.002.002.002.00
 单季度总资产净利率ROA(%) --1.001.001.001.001.00
单季度财务摘要:
 单季度营业总收入(元) 302,160,743.00364,758,065.00406,703,156.00420,328,605.00386,881,442.00425,804,492.00403,241,818.00
 单季度营业总成本(元) 279,734,032.00342,958,879.00340,912,235.00372,518,793.00311,342,204.00371,234,743.00349,719,742.00
 单季度营业收入(元) 302,160,743.00364,758,065.00406,703,156.00420,328,605.00386,881,442.00425,804,492.00403,241,818.00
 单季度营业利润(元) 28,529,608.0029,670,720.0058,680,287.0071,195,251.0066,313,453.0041,756,061.0046,679,557.00
 单季度利润总额(元) 27,278,338.0029,433,386.0057,699,012.0073,300,581.0066,496,336.0043,965,998.0046,751,755.00
 单季度净利润(元) 23,756,477.0024,336,463.0052,378,184.0052,773,745.0056,212,808.0042,567,522.0041,870,661.00
 单季度归属母公司股东的净利润(元) 22,317,909.0022,390,129.0050,822,917.0050,979,443.0054,801,703.0041,178,982.0041,102,886.00
 单季度经营活动产生的现金流量(元) 124,079,293.0050,790,689.00110,516,833.00108,538,664.0071,408,227.0058,651,939.0066,998,644.00
 单季度投资活动产生的现金流量(元) -17,617,089.00-7,645,965.00-12,045,611.00-11,883,083.00-9,818,109.00-4,385,158.00-71,050,197.00
 单季度筹资活动产生的现金流量(元) -98,496,117.00-40,648,795.00-221,122,267.00-18,576,320.00-179,319,205.0068,410,215.008,761,039.00
 单季度现金及现金等价物净增加(元) 8,215,683.002,493,954.00-122,652,566.0078,079,825.00-117,730,785.00122,677,114.004,709,094.00

前瞻产业研究院